Navigation Links
Kenneth Kensey, Inventor of the Angio-Seal(R), Dies at 58
Date:7/9/2009

PHILADELPHIA, June 9 /PRNewswire/ -- Kenneth R. Kensey, prolific inventor, successful entrepreneur and progressive physician, died July 3rd at Reading Hospital in West Reading, Pennsylvania of brain hemorrhage. Dr. Kensey, co-founder of Kensey-Nash Corporation, is the inventor or co-inventor in more than 130 patent filings with more than 50 patents issued. He was 58.

The inventor of the Angio-Seal(R) artery plug and the Rheolog(R) blood viscometer, Kensey made significant contributions to minimally invasive surgery and was recognized as a pioneer for his theories on the cause of heart disease.

Kensey was born in Everett, PA, the son of Edward I. Kensey and Fay L. Ritchey Kensey. He graduated from Ohio Wesleyan University and received his medical degree from Ohio State University. After a cardiology fellowship at Michael Reese Hospital in Chicago, Kensey entered private practice where he began to see the need for innovations in the device technologies used in medicine.

With John E. Nash, Kensey founded Kensey-Nash Corporation in 1984, where he was responsible for creating numerous new medical technologies including the Angio-Seal(R), the leading femoral artery puncture closure device marketed by St. Jude Medical, as well as the Kensey Catheter for Dynamic Angioplasty. Dr. Kensey's devices are in use worldwide. His inventions have contributed to saving millions of lives.

During his tenure as CEO of Kensey-Nash, Kensey was instrumental in facilitating joint ventures with Baxter Health Care, Johnson & Johnson, American Home Products, Cordis, and Tyco Medical.

In 1998, Kensey left Kensey-Nash to form Rheologics, Inc. (formerly, Visco Technologies, Inc.), where he developed the first in-vivo blood viscometer for use at the bedside in the diagnosis and treatment of atherosclerosis. He served as CEO of Rheologics until 2005 and Chairman until 2009.

Kensey was the author of 17 journal articles, including contributions to the Journal of Invasive Cardiology and the Review of Scientific Instruments. He co-wrote The Origin of Atherosclerosis: What Really Initiates the Inflammatory Process, and The Blood Thinner Cure: A Revolutionary Seven-Step Lifestyle Plan for Stopping Heart Disease and Stroke. He was an invited lecturer at Harvard Medical School, the American College of Cardiology, Stanford University, the Mayo Clinic, UCLA, and the Arizona Heart Institute.

ProMetrics, Inc., based in King of Prussia, PA and formed in 1994, is an active investor in emerging medical technology and service companies. In 2007 ProMetrics invested in SLIM Tech, LLC, a development stage medical device company based on Dr. Kensey's patents for an implantable lymphatic device to remove lipids. Dr. Kensey was directing the research effort for SLIM Tech, LLC.


'/>"/>
SOURCE Prometrics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Siemens Congratulates Kenneth R. Bertka, M.D., Recipient of 2007 AMDIS Award
2. Kenneth A. Sylvia Named as New Publisher of Current Psychiatry
3. Leading Autism Expert Kenneth A. Bock, M.D. Launches National Foundation to Provide Financial Assistance to Children with Autism, Allergies, Asthma and ADHD
4. Dr. Kenneth L. Byrd Joins SteriFx Inc.
5. The Kenneth B. Schwartz Center, ASTRO partner to raise awareness of cancer survivorship
6. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
7. Kenneth L. Reed, M.D. Performs First State of the Art AccuraScope(TM) Procedure in Dallas
8. Collegiate Inventors Competition(R) Announces Winners for 2007
9. Collegiate Inventors Competition announces winners for 2007
10. SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth
11. National Inventors Hall of Fame announces 2008 inductees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: